Londamocitinib

Details

Stereochemistry	ABSOLUTE
Molecular Formula	C28H31F2N7O4S
Molecular Weight	599.652
Optical Activity	UNSPECIFIED
Defined Stereocenters	1 / 1
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

COC[C@@H](N1CCN(C)CC1)C(=O)NC2=CC=CC3=C2NC=C3C4=NC(NC5=CC=CC(=C5F)S(C)(=O)=O)=NC=C4F

InChI

InChIKey=JNUZADQZHYFJGW-JOCHJYFZSA-N

InChI=1S/C28H31F2N7O4S/c1-36-10-12-37(13-11-36)22(16-41-2)27(38)33-21-8-4-6-17-18(14-31-26(17)21)25-19(29)15-32-28(35-25)34-20-7-5-9-23(24(20)30)42(3,39)40/h4-9,14-15,22,31H,10-13,16H2,1-3H3,(H,33,38)(H,32,34,35)/t22-/m1/s1

HIDE SMILES / InChI

Approval Year

Name

Type

Language

Londamocitinib

Common Name

English

londamocitinib [INN]

Common Name

English

AZD-4604

Code

English

AZD4604

Code

English

(R)-N-(3-(5-Fluoro-2-((2-fluoro-3-(methylsulfonyl)phenyl)amino)pyrimidin-4-yl)-1H-indol-7-yl)-3-methoxy-2-(4-methylpiperazin-1-yl)propanamide

Common Name

English

1-Piperazineacetamide, N-[3-[5-fluoro-2-[[2-fluoro-3-(methylsulfonyl)phenyl]amino]-4-pyrimidinyl]-1H-indol-7-yl]-α-(methoxymethyl)-4-methyl-, (αR)-

Systematic Name

English

Code System Code Type Description

PUBCHEM

135240395

Created by admin on Sat Dec 16 18:28:27 GMT 2023 , Edited by admin on Sat Dec 16 18:28:27 GMT 2023

PRIMARY

INN

12630

Created by admin on Sat Dec 16 18:28:27 GMT 2023 , Edited by admin on Sat Dec 16 18:28:27 GMT 2023

PRIMARY

CAS

2241039-81-4

Created by admin on Sat Dec 16 18:28:27 GMT 2023 , Edited by admin on Sat Dec 16 18:28:27 GMT 2023

PRIMARY

FDA UNII

JAC34RRR7S

Created by admin on Sat Dec 16 18:28:27 GMT 2023 , Edited by admin on Sat Dec 16 18:28:27 GMT 2023

PRIMARY

ACTIVE MOIETY


					JAC34RRR7S

Londamocitinib